Human immunodeficiency virus (HIV-1)is the major cause of acquired immunodeficiency syndrome (AIDS) in humans. The HIV-1 envelope glycoproteins, gp120 and gp41, are contained in trimeric complexes on the virion surface. The gp120 envelope glycoprotein mediates virus attachment to target cell receptors, CD4 and the chemokine receptors, CCR5 or CXCR4. Receptor binding triggers conformational changes in the HIV-1 envelope glycoproteins leading to the fusion of the viral and target cell membranes, a process mediated by the gp41 transmembrane envelope glycoprotein. The HIV-1 envelope glycoproteins and receptors represent potential targets for pharmacologic intervention. The envelope glycoproteins are the sole target for virus-neutralizing antibodies and are likely to be an important component in an effective vaccine against HIV-1 infection. Both therapeutic and prophylactic approaches would benefit from information on the structure of the HIV-1 envelope glycoproteins and the receptors. The overall goal of this proposal is to achieve an atomic level understanding of the structural biology associated with the HIV-1 envelope glycoproteins, receptors and neutralizing antibodies.
In Specific Aim 1, the structure of the monomeric HIV-1 gp120 glycoprotein in several different contexts will be determined.
In Specific Aim 2, an attempt will be made to determine structures of HIV-1 envelope glycoprotein trimers.
In Specific Aim 3, the structure of the CCR5 and CXCR4 chemokine receptors will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040895-10
Application #
7009299
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (01))
Program Officer
Wassef, Nabila M
Project Start
1996-12-15
Project End
2008-01-31
Budget Start
2006-02-01
Budget End
2008-01-31
Support Year
10
Fiscal Year
2006
Total Cost
$594,734
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Xiang, Shi-Hua; Finzi, Andrés; Pacheco, Beatriz et al. (2010) A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J Virol 84:3147-61
Yuan, Wen; Li, Xing; Kasterka, Marta et al. (2009) Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies. AIDS Res Hum Retroviruses 25:319-28
Kassa, Aemro; Madani, Navid; Schön, Arne et al. (2009) Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domain. J Virol 83:8364-78
Kassa, Aemro; Finzi, Andres; Pancera, Marie et al. (2009) Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation. J Virol 83:4476-88
Huang, Chih-chin; Tang, Min; Zhang, Mei-Yun et al. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310:1025-8
Rizzuto, C D; Wyatt, R; Hernandez-Ramos, N et al. (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-53